Current and future therapies for advanced pancreatic cancer
- PMID: 28591939
- DOI: 10.1002/jso.24623
Current and future therapies for advanced pancreatic cancer
Abstract
Pancreatic cancer remains a deadly disease with a 5-year survival rate of only 8%. Even after surgical resection, most patients have recurrence of their cancer. Over the last 10 years, improvements in chemotherapy regimens led to a doubling in median overall survival. Here we review the management of advanced pancreatic cancer and highlight vaccine therapy as a novel modality of treatment.
Keywords: cytotoxic chemotherapy; pancreas cancer; vaccine therapy.
© 2017 Wiley Periodicals, Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
